Literature DB >> 4001877

Prevalence and mortality rates of systemic lupus erythematosus and causes of death in SLE patients in Finland.

T Helve.   

Abstract

Nationwide prevalence and mortality rates in systemic lupus erythematosus (SLE) were estimated using a computer file of all hospital discharge records and cause of death statistics from 1972 to 1978. Age-specific and sex-specific prevalence rates obtained from 1976 to 1978 and mortality rates from 1972 to 1978. In December 1978 the prevalence of SLE was 28:100 000. The overall mortality rate was 4.7 per million person-years in 1972-78. Active lupus nephritis, vascular events and infections were the most frequent causes of death in SLE patients.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4001877     DOI: 10.3109/03009748509102015

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  13 in total

1.  The human GIMAP5 gene has a common polyadenylation polymorphism increasing risk to systemic lupus erythematosus.

Authors:  Anna Hellquist; Marco Zucchelli; Katja Kivinen; Ulpu Saarialho-Kere; Sari Koskenmies; Elisabeth Widen; Heikki Julkunen; Andrew Wong; Marja-Liisa Karjalainen-Lindsberg; Tiina Skoog; Johanna Vendelin; Deborah S Cunninghame-Graham; Timothy J Vyse; Juha Kere; Cecilia M Lindgren
Journal:  J Med Genet       Date:  2007-01-12       Impact factor: 6.318

2.  Smoking, disease activity, permanent damage and dsDNA autoantibody production in patients with systemic lupus erythematosus.

Authors:  Susanne Ekblom-Kullberg; Hannu Kautiainen; Pirkko Alha; Marjatta Leirisalo-Repo; Aaro Miettinen; Heikki Julkunen
Journal:  Rheumatol Int       Date:  2013-10-30       Impact factor: 2.631

Review 3.  [Accelerated atherosclerosis in rheumatic systemic diseases as an example of systemic lupus erythematosus--what is the consequence?].

Authors:  R Fischer-Betz; S Beer; M Schneider
Journal:  Z Rheumatol       Date:  2005-05       Impact factor: 1.372

4.  Estimating disease prevalence and incidence using administrative data: some assembly required.

Authors:  Michael M Ward
Journal:  J Rheumatol       Date:  2013-08       Impact factor: 4.666

5.  Outcome of a cohort of 300 patients with systemic lupus erythematosus attending a dedicated clinic for over two decades.

Authors:  K E Moss; Y Ioannou; S M Sultan; I Haq; D A Isenberg
Journal:  Ann Rheum Dis       Date:  2002-05       Impact factor: 19.103

6.  Report of an international symposium on narrowing the Gap in the treatment and study of SLE worldwide: minimum best practices in the management and monitoring of moderate to severe SLE and improving outcomes in constrained environments.

Authors:  Cindy H Flower; Anselm J M Hennis; Matthew H Liang
Journal:  Curr Rev Musculoskelet Med       Date:  2011-09

7.  Systemic lupus erythematosus in Saudi patients.

Authors:  S R Alballa
Journal:  Clin Rheumatol       Date:  1995-05       Impact factor: 2.980

8.  Short-term perioperative all-cause mortality and cardiovascular events in women with systemic lupus erythematosus.

Authors:  Ali Yazdanyar; Mary Chester Wasko; Lisabeth V Scalzi; Kevin L Kraemer; Michael M Ward
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-06       Impact factor: 4.794

9.  Prevalence of systemic lupus erythematosus in England and Wales, 1981-2.

Authors:  M C Hochberg
Journal:  Ann Rheum Dis       Date:  1987-09       Impact factor: 19.103

Review 10.  The epidemiology of systemic lupus erythematosus.

Authors:  Sònia Jiménez; Ricard Cervera; Josep Font; Miguel Ingelmo
Journal:  Clin Rev Allergy Immunol       Date:  2003-08       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.